Sabra Health Care REIT, Inc. (SBRA) Fair Value 2026

SBRA · REIT - Healthcare Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.4 /10

32 fundamental signals · 8 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-08-28, Sabra Health Care REIT, Inc. (SBRA) trades at $20.61, versus a $11.93 median fair value across its 8 active models — 42.1% below the current price. QOC: 7.4/10. Value Trap Risk: 12/100 (SAFE). 8/13 models active.

Key Facts

Ticker
SBRA
Price
$20.61
Quality Score
7.4/10
Value Trap Risk
12/100
Models Active
8/13
Last Updated
Strength: 8 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Sabra Health Care REIT, Inc. (SBRA) Undervalued or Overvalued in 2026?

According to CirclFi’s 8-model valuation engine, Sabra Health Care REIT, Inc. (SBRA) appears overvalued as of : the median of 8 independent fair value estimates is $11.93, 42.1% below the current price of $20.61. Estimates range from $2.87 to $21.57. SBRA scores 7.4/10 on fundamental quality and 12/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. SBRA’s -42.1% gap is wider than that market norm, and the REIT - Healthcare Facilities sector median is -45.3%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Sabra Health Care REIT, Inc. Stock in 2026? →

What Fair Value Does Each Model Give SBRA?

8 Intrinsic Value Models vs. Current Price ($20.61)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $10.11 -51.0%
Intrinsic · High Conviction
 $11.83 -42.6%
Intrinsic · High Conviction
 $3.95 -80.8%
Asset-Based · High Conviction
 $2.87 -86.1%
Unlock the Full Matrix

Access 4 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 8 Models →

Cancel anytime · No contracts · Instant access

What Is SBRA's Fair Value Range?

Spread across 8 independent models · $2.87 to $21.57

CirclFi's 8 active models place Sabra Health Care REIT, Inc. (SBRA) between $2.87 and $21.57 per share, a spread of 157% of the median. The median of that range — $11.93 — is the fair value CirclFi publishes for SBRA, against a current price of $20.61.

Low · Dynamic NAVHigh · Regime Cross
$2.87median $11.93$21.57
Where the range comes from
Most bearish modelDynamic NAV$2.87
Most bullish modelRegime Cross-Sectional$21.57
Model agreement0 bullish · 7 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for SBRA. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on SBRA, not a CirclFi price target. How each model works →

What Is Sabra Health Care REIT, Inc. (SBRA) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Sabra Health Care REIT, Inc.'s intrinsic value is estimated at $11.93. Trading at its current price of $20.61, the valuation engine raises significant caution: 7 of 8 models flag downside risk, projecting a median implied return of -42.1%. Model dispersion is worth noting: Regime Cross targets $21.57 (+4.6%), versus Dynamic NAV at $2.87 (-86.1%). This +90.7% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About SBRA?

8 of 13 models are currently active for SBRA. Of these, 1 model suggests upside while 7 models suggest overvaluation. Taken together, their median fair value for SBRA is $11.93 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does SBRA Rank in REIT - Healthcare Facilities?

Among 17 REIT - Healthcare Facilities stocks, SBRA ranks #7 by Quality of Company score. CirclFi's QOC score of 7.4/10 evaluates 32 fundamental signals. A score of 7.4 indicates above-average quality.

The REIT - Healthcare Facilities sector introduces analytical considerations specific to biopharma enterprise businesses. For Sabra Health Care REIT, Inc., metrics like FDA approval probability provide important context that general-purpose valuation models may underweight.

Is SBRA a Value Trap?

CirclFi's Value Trap algorithm assigns SBRA a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

8 of 13 models are active for Sabra Health Care REIT, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Sabra Health Care REIT, Inc. scores 7.4 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +90.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SBRA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SBRA's 8 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Sabra Health Care REIT, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar REIT - Healthcare Facilities Stocks Should You Also Analyze?

10 related REIT - Healthcare Facilities stocks with 13-model coverage

LTCLTC Properties, Inc.QOC 8.0DOCHealthpeak Properties, Inc.QOC 7.2UHTUniversal Health Realty Income TrustQOC 8.1CHCTCommunity Healthcare Trust IncorporatedQOC 7.2WELLWelltower Inc.QOC 8.1NHINational Health Investors, Inc.QOC 7.2STRWStrawberry Fields REIT, Inc.QOC 7.0XRNChiron Real Estate Inc.QOC 5.9OHIOmega Healthcare Investors, Inc.QOC 8.5CTRECareTrust REIT, Inc.QOC 8.6

Read investment analysis: LTC · DOC · UHT · CHCT · WELL · NHI · STRW · XRN · OHI · CTRE

Which Other Stocks Have a Similar Quality Score to SBRA?

7 companies across all industries closest to SBRA’s Quality of Company score of 7.4/10.

DEODiageo plcQOC 7.4FNWDFinward BancorpQOC 7.4RSVRReservoir Media, Inc.QOC 7.4SCLStepan CompanyQOC 7.4SITMSiTime CorporationQOC 7.4TACTTransAct Technologies IncorporatedQOC 7.4NVDANVIDIA CorporationQOC 10.0

Read investment analysis: DEO · FNWD · RSVR · SCL · SITM · TACT · NVDA

What Else Do Investors Ask About Sabra Health Care REIT, Inc.’s Valuation?

What is Sabra Health Care REIT, Inc.'s intrinsic value in 2026?

CirclFi puts Sabra Health Care REIT, Inc. (SBRA)'s intrinsic value at $11.93 — the median of 8 independent model estimates as of 2026-08-28, ranging from $2.87 to $21.57. The Quality of Company score is 7.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SBRA overvalued or undervalued right now?

At $20.61, 1 of 8 active models suggest SBRA may be undervalued, while 7 indicate potential overvaluation. The median of all 8 fair value estimates is $11.93, 42.1% below the current price of $20.61 — a consensus view that SBRA is overvalued. The assessment depends on which methodology best fits Sabra Health Care REIT, Inc.'s business model in REIT - Healthcare Facilities.

What does a Quality of Company score of 7.4 mean for SBRA?

Sabra Health Care REIT, Inc.'s QOC of 7.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on SBRA?

CirclFi analyzes SBRA with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 8 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on SBRA?

Of the 8 models currently active on SBRA, Regime Cross-Sectional is the most bullish at $21.57 per share, and Dynamic NAV is the most bearish at $2.87. CirclFi's published fair value for SBRA is the median of that range, $11.93, not either extreme. The gap between the two ends equals 157% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is SBRA a value trap in 2026?

Sabra Health Care REIT, Inc.'s Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 8-model valuation engine, Sabra Health Care REIT, Inc. (SBRA) has a median fair value of $11.93 — 42.1% below the current price of $20.61 — as of 2026-08-28.” Source: circlfi.com/stock/SBRA/ · Methodology
Primary sources for this SBRA valuation
  • Financial statements: Sabra Health Care REIT, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001492298) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SBRA as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 8 mathematical frameworks give you clarity on SBRA.

Unlock All 8 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for SBRA Unlock All 8 — $39/mo